Eva LaDow

Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models

Hyung‐Jun Kim, Alya R. Raphael, Eva LaDow et al. · Nature Genetics · 2013 · 377 citations · Full text

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Signal Transduction +10

Rapid Target-Specific Remodeling of Fast-Spiking Inhibitory Circuits after Loss of Dopamine

Aryn H. Gittis, Giao B. Hang, Eva LaDow et al. · Neuron · 2011 · 177 citations · Full text

Synaptic Plasticity, Neurodynamics, Neurophysiology +13

Structure-Guided Inhibitor Design Expands the Scope of Analog-Sensitive Kinase Technology

Chao Zhang, Michael S. Lopez, Arvin C. Dar et al. · ACS Chemical Biology · 2013 · 58 citations · Full text

Systems Biology, Engineering, General As-kinase Inhibitors +15

Microarray Analyses of Genes Regulated by Isoflurane Anesthesia In Vivo

Scott D. Edmands, Eva LaDow, Adam C. Hall · Anesthesia & Analgesia · 2013 · 17 citations · Full text

A Three-Groups Model for High-Throughput Survival Screens

Benjamin A. Shaby, Gaia Skibinski, D. Michael Ando et al. · Biometrics · 2016 · 10 citations · Full text

Engineering, High-throughput Survival Screens, Neurochemical Biomarkers +17